课题基金 / 基金详情

Genetic disorders of human neurological and immune function

Genetic disorders of human neurological and immune function
人类神经和免疫功能的遗传性疾病
批准号:
MC_UU_00035/11
负责人:
Yanick Crow
金额:
$581.93万
依托单位:
依托单位国家:
英国
项目类别:
Intramural
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

Yanick Crow的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Crow laboratory has two main interests. Firstly, we study a chemical called interferon, which acts as a kind of cellular disinfectant that kills viruses. Like a disinfectant, too much interferon is dangerous. Interferon is normally only produced when cells sense the presence of viral genetic material (DNA and RNA). However, we have identified patients in whom interferon is high in the absence of viral infection, due to the cell misinterpreting our own DNA and RNA as coming from a virus, and the subsequent triggering of interferon production. We are interested in how cells normally avoid such sensing of ‘self’ as ‘non-self’, and what happens when these mechanisms fail. In a second research theme, we study a rare disease of the blood vessels of the brain called Labrune syndrome, which we discovered to arise due to changes in a piece of genetic material called SNORD118. We have developed a zebrafish which does not have SNORD118. Using this model, we want to understand how the blood vessels in our brain are kept healthy, and how problems with the function of SNORD118 cause disease. This could be relevant not only for the development of future treatments for Labrune syndrome, but also in our understanding of more common disorders of the brain blood vessels, such as stroke.We work closely with affected families, using samples that are provided by patients for our research, together with specialised tests and animal models, to better understand and treat the devastating diseases described above.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s10875-024-01660-6
发表时间: 2024-02
期刊: Journal of Clinical Immunology
影响因子: 9.1
作者: [Clémence David;Mihaly Badonyi;Robin Kechiche;Antonella Insalaco;M. Zecca;Fabrizio de Benedetti]
通讯作者: Clémence David;Mihaly Badonyi;Robin Kechiche;Antonella Insalaco;M. Zecca;Fabrizio de Benedetti
Investigation of the role of the snoRNA U8 in human health and disease
  • 批准号:
    MR/V009273/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $77.4万
  • 财政年份:
    2021
  • 负责人:
    Yanick Crow
  • 依托单位:
Replication-dependent histone pre-mRNA misprocessing and innate immune sensing
  • 批准号:
    MR/V000195/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $79.91万
  • 财政年份:
    2020
  • 负责人:
    Yanick Crow
  • 依托单位:
Inhibition of reverse transcription in type I interferon mediated neuropathology
  • 批准号:
    MR/S034676/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $219.09万
  • 财政年份:
    2020
  • 负责人:
    Yanick Crow
  • 依托单位:
ERA-NET NEURON: Investigation of the neuroinflammatory basis of the human type I
  • 批准号:
    MR/M501803/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $35.62万
  • 财政年份:
    2015
  • 负责人:
    Yanick Crow
  • 依托单位:
国内基金
海外基金
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
  • 批准号:
    82371867
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王剑
  • 依托单位:
UBIAD1调控Ras信号的机制研究
  • 批准号:
    32100587
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    许志亮
  • 依托单位:
溶酶体贮积症细胞内胆固醇累积导致患者神经元死亡的细胞与分子机制
  • 批准号:
    32100621
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李平
  • 依托单位:
SAGE1通过调控TERT转录促进肿瘤细胞增殖的机制研究
  • 批准号:
    32100582
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    葛云辉
  • 依托单位: